ljc 10627 has been researched along with Acinetobacter Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, L; Liu, M; Rao, Q; Wang, S; Yang, Y; Zhang, J; Zhu, H | 1 |
| Li, X; Lu, C; Sun, S; Wang, D; Wang, Y | 1 |
2 other study(ies) available for ljc 10627 and Acinetobacter Infections
| Article | Year |
|---|---|
Optimal dosing regimen of biapenem based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulation in patients with febrile neutropenia and haematological malignancies.
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Febrile Neutropenia; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Prospective Studies | 2023 |
In vitro interactions of ambroxol hydrochloride or amlodipine in combination with antibacterial agents against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ambroxol; Amlodipine; Anti-Bacterial Agents; Carbapenems; Cefoperazone; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 2020 |